Eli Lilly’s Phase III SURPASS-2 clinical trial shows that treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist, is associated with superior reductions in body weight and blood sugar compared with injectable semaglutide in adults with type 2 diabetes.
If you are not happy with the results below please do another search
50 search results for:
Alabama’s governor on March 4 extended for another month an order mandating residents to wear face masks to protect against Covid-19, breaking with Mississippi and Texas as the issue again becomes the focus of political debate.
Doceree Founder and CEO Harshit Jain, MD, discusses how pharma brands can raise the ROI of digital marketing campaigns.
Anjum Swaroop, Vice President and Head – Intellectual Property, Dr. Reddy’s Laboratories, addresses the intellectual property issues healthcare companies are facing in the time of Covid-19.
One year after submitting a New Drug Application for Azstarys, the U.S. Food and Drug Administration approved KemPharm’s novel ADHD drug for use in patients 6 years and older.
Another study is adding to a growing body of literature that suggests convalescent plasma from recovered patients with Covid-19 does not prevent further Covid-19 progression in at-risk people who visit the emergency room.
Built In Chicago announced the selection of digital-native marketing agency closerlook inc. as one of the Best Places to Work in the online community’s 2021 round up.
CureVac NV inked a deal with Switzerland’s Novartis AG to manufacture the German biopharmaceutical company’s Covid-19 vaccine candidate, CVnCoV.
Amgen is buying Five Prime Therapeutics for about $1.9 billion and adding a late-stage gastric cancer drug candidate to the drugmaker’s line of cancer treatments.
Europe’s medicines regulator said on March 4 that the EMA started a rolling review of Russia’s Sputnik V Covid-19 vaccine, an important display of confidence in the shot that paves the way for its potential approval across the 27-nation bloc.